TrialInternational journal of radiation oncology, biology, physics2017

A Phase 1/2 Trial of a Combination of Paclitaxel and Trastuzumab With Daily Irradiation or Paclitaxel Alone With Daily Irradiation After Transurethral Surgery for Noncystectomy Candidates With Muscle-Invasive Bladder Cancer (Trial NRG Oncology RTOG 0524).

M Dror Michaelson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.